Impact of GLP-1 Receptor Agonists on Major Gastrointestinal Disorders for Type 2 Diabetes Mellitus: A Mixed Treatment Comparison Meta-Analysis

Aim. We aimed to integrate evidence from all randomized controlled trials (RCTs) and assess the impact of different doses of exenatide or liraglutide on major gastrointestinal adverse events (GIAEs) in type 2 diabetes (T2DM). Methods. RCTs evaluating different doses of exenatide and liraglutide agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Feng, Yu, Kai, Yang, Zhirong, Wu, Shanshan, Zhang, Yuan, Shi, Luwen, Ji, Linong, Zhan, Siyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540917/
https://www.ncbi.nlm.nih.gov/pubmed/23365557
http://dx.doi.org/10.1155/2012/230624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540917/
https://www.ncbi.nlm.nih.gov/pubmed/23365557
http://dx.doi.org/10.1155/2012/230624

Ejemplares similares